Some investors might love biotech stocks for their lottery ticket-like returns when a company wins the FDA’s blessing. A lottery ticket, however, costs …
Adamis Pharmaceuticals (NASDAQ:ADMP) shares tumbled as much as 30% this month, prompting plenty of inquiries from investors. Dr.
Adamis Pharmaceuticals (NASDAQ:ADMP) is a mover and shaker out on the Street today, with investors sparking the stock on an almost 45% upturn. …
What does the future hold for Adamis Pharmaceuticals Corporation (NASDAQ:ADMP)? Raymond James analyst Elliot Wilbur is out today with a bullish note on …
With the tremendous focus on the opioid crisis, Raymond James’ Elliot Wilbur sees exciting potential for Adamis.
Adamis Pharmaceuticals (NASDAQ:ADMP) investors sent the stock on a nearly 9% gain in value yesterday on back of the news of the company’s …
